SD

Shankar Dayal Singh

Active Director Director DIN 11566023
DIN 11566023 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shankar Dayal Singh

Data last updated:

Shankar Dayal Singh is a Director at Curogem Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11566023
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 20262026Active

Board colleagues of Shankar Dayal Singh

NameDINCompanyDesignation
Devi Dayal Singh11566022Curogem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curogem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shankar Dayal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shankar Dayal Singh

Shankar Dayal Singh currently holds 1 directorship: Curogem Pharmaceuticals Private Limited (Director, since 23 Feb 2026).

Shankar Dayal Singh was first appointed on 23 Feb 2026 as Director at Curogem Pharmaceuticals Private Limited.

The current boards of Shankar Dayal Singh's companies include Devi Dayal Singh (Curogem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available